New Genomic Medicine Collaboratory to serve as nexus for genetics, genomics community

strands of DNA
GCB News

New Genomic Medicine Collaboratory to serve as nexus for genetics, genomics community

Genomics and genomic medicine are rapidly evolving fields. As the power of genomics continues to be realized, Duke School of Medicine is placing a higher priority on genomics-based research. In “Leading the Next Generation of Discovery and Impact,” an extension to the 2016 Strategic Plan, Duke School of Medicine announced its intention to launch the new Duke Genomic Medicine Collaboratory as the nexus for the genetics and genomics community at Duke. The new collaboratory will spur innovations in precision medicine, genetics and genomics to achieve distinguished impacts in genetics-based discoveries, research methods, and translational to clinical care. CAGPM Director Geoff Ginsburg and GCB Director Greg Wray participated in the deliberations about the new collaboratory.

Related News

red blood cells

New Finding Could Unmask Blood Doping in Athletes

RNA changes mark old blood cells among new ones, foiling self-transfusions

view
Terrie Moffitt

Terrie Moffitt elected to National Academy of Medicine

Co-Director of Landmark Longitudinal Study in New Zealand

view
Greg Crawford, Kris Woods, Tim Reddy, and Charlie Gersbach

From Innovation to Impact

When four Duke researchers developed an innovative technique for exploring the non-coding genome—the 98 percent of our DNA that does not encode protein sequences, often called the genome’s “dark matter”—the implications were clear.
view